Meeting Coverage
The Current and Future Roles of Genetics in Psychiatry
Today, some patients are as apt to arrive in the clinic with genetic test results from 23andMe or...
Read More
Psych Congress 2019 Faculty
Faculty Agronin, Marc E. Senior Vice President, Behavioral Health Miami Jewish Health Ft....
Read More
ASCO 2019 VIDEO: J. Leonard Lichtenfeld, MD
J. Leonard Lichtenfeld, MD, Acting Chief Medical and Scientific Officer, American Cancer...
Read More
Dr. Diefenbach and Dr. Dale
Catherine M. Diefenbach, MD, ASCO Spokesperson; NYU Langone Health William Dale, MD, PhD, ASCO...
Read More
ASCO 2019 VIDEO: Monica M. Bertagnolli, MD, Immediate Past-President, ASCO
Monica M. Bertagnolli, MD, Immediate Past-President, ASCO
Read More
ASCO 2019 Clinical Challenge: Are You an ASCO 2019 Expert?
The lights are out, the banners down, and the overflow rooms empty as the American Society of...
Read More
Conference Highlights: EULAR 2019
New research and recommendations were presented at EULAR 2019, the European League Against...
Read More
ASCO 2019: It Really Is All About the Targets
A quick run through the highlights and the headlines from the world’s biggest cancer meeting....
Read More
Conference Highlights: ADA 2019
New research was presented at ADA 2019, the 79th Scientific Sessions of American Diabetes...
Read More
ASCO 2019: Investigational AKT Inhibitor Holds Promise in ER+ Disease
Potency is clear, but for capivasertib, toxicity is an issue CHICAGO – In a small study of...
Read More
ASCO 2019: Test All Triple Negative Breast Cancer Patients for PD-L1
Latest analysis from IMpassion trial confirms need for testing CHICAGO— One of the repeated themes...
Read More
ASCO 2019: Palbociclib Extends PFS in Young Women with HR+/HER2 Metastatic Breast Cancer
Korean study is first to show palbociclib benefit in premenopausal women CHICAGO—A second trial of...
Read More
ASCO 2019: NALA III Results Find ‘Modest Benefit’ for Neratinib Plus Capecitabine in Metastatic Breast Cancer
Findings hint at CNS benefit for neratinib By Peggy Peck, Editor-in-Chief, BreakingMED CHICAGO —A...
Read More
ASCO 2019: A Metavivor Offers Advice to Clinicians Treating Metastatic Breast Cancer
‘Don’t call my disease chronic.’ By Peggy Peck, Editor-in-Chief, BreakingMED CHICAGO — Kelli Davis...
Read More
ASCO 2019: SOPHIA Findings Pave Way for a New Tx Option in HER2+ Metastatic Breast Cancer
Benefit greatest in CD16A-158F carriers By Peggy Peck, Editor-in-Chief, BreakingMED CHICAGO...
Read More
ASCO 2019: CDK4/6 Inhibitors New Standard of Care for First-Line Tx
MONALEESA-7 results push the practice change needle By Peggy Peck, Editor-in-Chief, BreakingMED...
Read More
ASCO 2019: Researchers Hunt for Breast Cancer Resistance Genes
Pathways that get around PARP inhibitors explored CHICAGO – The cyclin-dependent kinase (CDK) 4/6...
Read More
ASCO 2019: Right to Try Act a Dud?
After a year, just 2 cases reported by FDA CHICAGO —At the one-year mark, the Right to Try Act,...
Read MoreASCO 2019: Adding Clinical Risk to Gene Scoring Predicts Likelihood of Breast Cancer Recurrence
More from TAILORx investigators By Peggy Peck, Editor-in-Chief, BreakingMED CHICAGO — Clinical risk — high versus low risk — integrated into a genomic risk model is prognostic of distant recurrence of breast cancer in women...
Read More